NCT00772538 Evaluation of Tiotropium 5 µg/Day Delivered Via the Respimat® Inhaler Over 48 Weeks in Patients With Severe Persistent Asthma on Top of Usual Care (Study I) Status COMPLETED Phase PHASE3
NCT00771992 Ex Vivo Effect of Surfactant Protein D on Pulmonary Immune Cells Derived From Bronchoalveolar Lavage After Segmental Allergen Challenge in Patients With Asthma Status COMPLETED Phase NA
NCT00770900 Study to Evaluate the Inflammatory Cells Activity in Patients With Persistent Asthma Treated With Montelukast (0476-403)(COMPLETED) Status COMPLETED Phase PHASE4
NCT00768170 MK0633 Single Dose Study in Japanese Asthmatic Children Aged 12 to Less Than 16 Years (0633-028) Status COMPLETED Phase PHASE1
NCT00768079 A Phase 2 Study to Evaluate the Safety and Efficacy of Intravenously Administered Benralizumab (MEDI-563). Status COMPLETED Phase PHASE2
NCT00766090 Safety and Efficacy of GW685698X an Inhaled Corticosteroid Once Daily and Twice Daily for the Treatment of Asthma Status COMPLETED Phase PHASE2
NCT00763035 Comparison of Dobutamine and Regadenoson Stress Cardiac Magnetic Resonance (MR) Status TERMINATED Phase EARLY_PHASE1
NCT00758589 One Month Dose Response Study of AZD1981 in Asthma Patients Uncontrolled on Inhaled Steroids Status COMPLETED Phase PHASE2
NCT00756418 Montelukast Post-marketing Comparative Study With Theophyline Added to Inhaled Corticosteroid (0476-396) Status COMPLETED Phase PHASE4
NCT00755794 The Singulair® add-on Study Effectiveness of Adding Montelukast to Inhaled Corticosteroids in Adult Subjects With Uncontrolled Asthma (0476-384) Status COMPLETED Phase PHASE3
NCT00749528 Evaluation of Toxic Metals, Trace Elements and Total Antioxidant Activity in Children With Recurrent Wheezing Status COMPLETED Phase N/A
NCT00747318 A Phase 3, Multicenter, Open-label Continuation Study in Moderate to Severe Asthmatic Subjects Who Completed FlutiForm HFA pMDI Study SKY2028-3-005 Status COMPLETED Phase PHASE3
NCT00746330 Single Dose Study of the Effect of Formoterol Fumarate in Combination With Mometasone Furoate Inhaled Via a Pressurized Metered Dose Inhaler (pMDI) in Children Aged 5-11 Years Old With Persistent Asthma Status COMPLETED Phase PHASE2
NCT00744614 Use Of Capnography As Surrogate Measure Of PC02 In Medical Intensive Care Unit (ICU) Patients Status TERMINATED Phase N/A